These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 421713)

  • 1. Leukocyte adherence inhibition and immunoreactivity in prostatic cancer. II. Tissue- and disease-specificity of antitumour cell-mediated immunity.
    Bhatti RA; Ablin RJ; Guinan PD
    Eur J Cancer (1965); 1979 Jan; 15(1):133-6. PubMed ID: 421713
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell-mediated immunity in prostatic cancer.
    Ablin RJ; Bhatti RA; Nagubadi S; Zamora S; Guinan PD
    Clin Oncol; 1980 Sep; 6(3):253-64. PubMed ID: 7428203
    [No Abstract]   [Full Text] [Related]  

  • 3. Leukocyte migration inhibition assay in patients with prostate adenocarcinoma.
    Wright GL; Schellhammer PF; Faulconer RJ; Reid JW; Brassil DN; Sieg SM
    Prostate; 1981; 2(2):121-31. PubMed ID: 6170963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated immunity in prostatic cancer and its diagnostic relevancy.
    Ablin RJ; Guinan PD; Bhatti RA
    Eur J Cancer Clin Oncol; 1983 Apr; 19(4):467-71. PubMed ID: 6190657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of sensitized leukocyte's in vitro reactivity by circulating immune complexes in prostate cancer.
    Bhatti R; Shaw M; Ray P
    Experientia; 1987 Aug; 43(8):916-7. PubMed ID: 3622734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of human seminal plasma on tumour-associated immunity in patients with adenocarcinoma of the prostate.
    Ablin RJ; Bhatti RA; Bush IM; Guinan PD
    J Reprod Immunol; 1980 Feb; 1(5-6):337-45. PubMed ID: 7411523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-associated immunity in prostatic cancer as evaluated by tube antigen-induced leukocyte adherence inhibition: reactivity and specificity of responsiveness, and relationship to stage, grade and therapy.
    Bhatti RA; Ablin RJ; Guinan PD
    J Reticuloendothel Soc; 1979 Apr; 25(4):389-95. PubMed ID: 458777
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunodiagnosis of prostate cancer: an evaluation of cell-mediated immunity.
    Bhatti RA; Guinan PD; Nagubadi SR; Khin W
    Prostate; 1982; 3(4):415-9. PubMed ID: 7122334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of estrogen on tumor-associated immunity in patients with adenocarcinoma of the prostate.
    Ablin RJ; Bhatti RA; Guinan PD
    Cancer Res; 1978 Nov; 38(11 Pt 1):3702-6. PubMed ID: 698929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further evaluation of the effect of estrogen on tumor-associated immunity in prostatic cancer.
    Ablin RJ; Bhatti RA; Guinan PD
    Isr J Med Sci; 1979 Jan; 15(1):9-11. PubMed ID: 422345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arming of normal leukocytes with sera from patients with adenocarcinoma of the prostate.
    Bhatti RA; Ablin RJ; Condoulis W; Guinan PD
    Cancer Res; 1979 Sep; 39(9):3328-31. PubMed ID: 476662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of leukocyte adherence inhibition test to study the cell mediated antitumour immunity in cancer patients.
    Shirodkar SR; Gangal SG
    Indian J Med Res; 1979 Jul; 70():88-96. PubMed ID: 387584
    [No Abstract]   [Full Text] [Related]  

  • 13. An evaluation of leukocyte adherence inhibition in the immunodiagnosis of colorectal cancer.
    Halliday WJ; Maluish AE; Stephenson PM; Davis NC
    Cancer Res; 1977 Jul; 37(7 Pt 1):1962-71. PubMed ID: 67885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of diethylstilboesterol diphosphate on tumour-assoiciated immunity in prostatic cancer. A preliminary report.
    Bhatti RA; Ablin RJ; Guinan PD; Totonchi E; Zamora S
    Experientia; 1978 Oct; 34(10):1364-5. PubMed ID: 738427
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. IV. Leucocyte adherence inhibition.
    Ablin RJ; Bhatti RA; Guinan PD; Bruns GR
    Urol Int; 1976; 31(6):459-69. PubMed ID: 795128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppression of cell- and serum-medicated tumour-associated immunity in prostatic cancer by human seminal plasma.
    Ablin RJ; Bhatti RA; Bush IM; Guinan PD
    Eur J Cancer (1965); 1980 Jun; 16(6):775-80. PubMed ID: 7408927
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. III. Inhibition of leucocyte migration.
    Ablin RJ; Marrow C; Guinan PD; Bruns GR; Sadoughi N; John T; Bush IM
    Urol Int; 1976; 31(6):444-58. PubMed ID: 1006873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of leukocyte migration by extracts of malignant prostatic tissue and correlation of degree of in vitro sensitization to clinical responsiveness in prostatic cancer patients.
    Ablin RJ; Bush IM; Bruns GR; John T; Sadoughi N; Guinan PD
    Urology; 1978 Mar; 11(3):289-92. PubMed ID: 565097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocyte adherence inhibition and immunoreactivity in prostatic cancer. I. Identification of anti-tumour cell-mediated immunity and "blocking" factor.
    Ablin RJ; Bhatti RA; Bruns GR; Guinan PD
    Eur J Cancer (1965); 1977 Jul; 13(7):699-703. PubMed ID: 598395
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppression of tumor-associated immunity by human seminal plasma and its possible role in the natural history of prostatic cancer.
    Ablin RJ; Bhatti RA; Bush IM; Guinan PD
    Eur Urol; 1980; 6(4):225-8. PubMed ID: 7389776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.